Miura, Shin-Ichiro
Suematsu, Yasunori
Matsuo, Yoshino
Tomita, Sayo
Nakayama, Asuka
Goto, Masaki
Arimura, Tadaaki
Kuwano, Takashi
Yahiro, Eiji
Saku, Keijiro
Article History
Received: 8 January 2016
Revised: 6 April 2016
Accepted: 11 April 2016
First Online: 23 June 2016
Competing interests
: KS is a Chief Director and SM is a Director of NPO Clinical and Applied Science, Fukuoka, Japan. KS has an Endowed Department, the ‘Department of Molecular Cardiovascular Therapeutics,’ that is supported by MSD, Co. Ltd. SM belongs to the Department of Molecular Cardiovascular Therapeutics supported by MSD, Co. Ltd.
Free to read: This content has been made available to all.